TY - JOUR
T1 - Development of the Treatment Adherence Survey-patient version (TAS-P) for OCD
AU - Mancebo, Maria C.
AU - Pinto, Anthony
AU - Rasmussen, Steven A.
AU - Eisen, Jane L.
N1 - Funding Information:
This work was supported by a grant (R01 MH060218) to Dr. Rasmussen from the National Institute of Mental Health, Bethesda, MD and a grant to Dr. Eisen from the Department of Psychiatry and Human Behavior, Brown Medical, Providence, RI. Special thanks to Drs. Benjamin Greenberg, Barbara VanNoppen, Matt Evans, and Dan Weiner for reviewing drafts of the instrument and Dawn Hamel, Meredith Mello, and Samantha Collum for data collection.
PY - 2008
Y1 - 2008
N2 - This paper reports on the development and initial psychometric evaluation of the Treatment Adherence Survey-patient version (TAS-P), a brief instrument designed to assess patient adherence to Cognitive-Behavioral Therapy (CBT) and pharmacotherapy recommendations for OCD. Eighty individuals with Obsessive Compulsive Disorder (OCD) were administered the TAS-P as part of the intake interview of a prospective, observational study of the course of OCD. Results demonstrated excellent test-retest reliability. Responses on the TAS-P were also significantly correlated with scores on a self-report measure of general treatment adherence and with data collected from a chart-review, demonstrating concurrent validity. Treatment adherence was not explained by demographic variables. However, participants who reported nonadherence to CBT recommendations had more severe OCD symptoms at the time of intake than those who did not endorse CBT nonadherence (mean Y-BOCS = 23.27 ± 7.5 versus 18.20 ± 8.0, respectively). Results suggest that the TAS-P is a promising instrument for assessing reasons for nonadherence to recommendations for CBT and pharmacotherapy interventions.
AB - This paper reports on the development and initial psychometric evaluation of the Treatment Adherence Survey-patient version (TAS-P), a brief instrument designed to assess patient adherence to Cognitive-Behavioral Therapy (CBT) and pharmacotherapy recommendations for OCD. Eighty individuals with Obsessive Compulsive Disorder (OCD) were administered the TAS-P as part of the intake interview of a prospective, observational study of the course of OCD. Results demonstrated excellent test-retest reliability. Responses on the TAS-P were also significantly correlated with scores on a self-report measure of general treatment adherence and with data collected from a chart-review, demonstrating concurrent validity. Treatment adherence was not explained by demographic variables. However, participants who reported nonadherence to CBT recommendations had more severe OCD symptoms at the time of intake than those who did not endorse CBT nonadherence (mean Y-BOCS = 23.27 ± 7.5 versus 18.20 ± 8.0, respectively). Results suggest that the TAS-P is a promising instrument for assessing reasons for nonadherence to recommendations for CBT and pharmacotherapy interventions.
KW - Cognitive-Behavioral Therapy
KW - Obsessive Compulsive Disorder
KW - Pharmacotherapy
KW - Psychometric properties
KW - Treatment adherence
UR - https://www.scopus.com/pages/publications/37249084668
U2 - 10.1016/j.janxdis.2007.01.009
DO - 10.1016/j.janxdis.2007.01.009
M3 - Article
C2 - 17324553
AN - SCOPUS:37249084668
SN - 0887-6185
VL - 22
SP - 32
EP - 43
JO - Journal of Anxiety Disorders
JF - Journal of Anxiety Disorders
IS - 1
ER -